Digital GI Health: Sam Holliday, CEO, Oshi Health – Part 2
Coordinating primary with specialty care, redesigning virtual GI care around patients

A continuation of Part 1. One of our B2B thought leadership interviews with digital health entrepreneurs working to improve care of chronic conditions. We care particularly about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. This continues our interview…

Bill Conlan & CrossBridge (Part 2)

See Part 1 for how Bonnie met Bill Conlan pre-CrossBridge and for background on his entrepreneurial track record. That background includes SaaS platforms, analytics and the migration from fee-for-service (FFS) to value-based payments (VBP). Part 1 also lays out the…

Bill Conlan & CrossBridge (Part 1)

Welcome to our B2B Thought Leadership series! We are delighted to start with a 2-part post from our interview with Bill Conlan, founder and CEO of CrossBridge. CrossBridge is a Software as a Service (SaaS) platform using data analytics to…

Home

Join us on our fight against the invisible epidemic of (auto)immunity. We provide thought leadership, advisory & consulting services as well as educational materials and community support. CONSULTING & COLLABORATION JOIN OUR PATIENT COMMUNITY Who We Are Empowering patients, Consulting…

Dr Kosinski, MD, MBA, SonarMD Founder

On GI practice, beta risk, digital health, VBP and chronic care Another in our new series of B2B thought leadership interviews with visionary entrepreneurs applying digital tools to improve care of chronic immunoinflammatory disorders (CID), including autoimmune and autoinflammatory diseases.…

Will Long COVID Change the Game for Autoimmune Diseases, too? Part 1

Will long-COVID activists, especially practitioner-patients, finally force healthcare systems, clinicians and medical researchers to confront post-viral and similar chronic syndromes they have shrugged off for decades? In keeping with our mission, will a focused response by healthcare systems and researchers to post-COVID syndrome help illuminate the invisible epidemic of autoimmune and autoinflammatory disorders?

:)